Concentra Group Holdings Parent, INC Form 4 insider transactions

Danielle Kendall, Senior Vice President of Human Resources at Concentra Group Holdings Parent, Inc., was granted 40,000 shares of restricted common stock.

Concentra Group Holdings Parent, Inc.'s Executive Vice President and Chief Accounting Officer, Nelson Su Zan, was granted 60,000 shares of common stock.

Concentra Group Holdings Parent, Inc.'s Chief Medical Officer, John Robert Anderson Jr., was granted 60,000 shares of restricted common stock.

Concentra Group Holdings Parent, Inc. reports an acquisition of 60,000 restricted common stock shares by Executive Vice President Jonathan P. Conser, vesting over four years.

Concentra Group Holdings Parent, Inc. Director Cheryl Pegus received a grant of 7,748 shares of restricted common stock, which will vest in full on November 4, 2026.

John A. deLorimier, Concentra's EVP and Chief Digital & Data Officer, was granted 60,000 restricted common shares vesting over four years.

Concentra Group Holdings Parent, Inc. executive Greg M. Gilbert was granted 60,000 shares of restricted common stock, vesting over four years.

Concentra Group Holdings Parent, Inc. director Marc R. Watkins was granted 7,748 shares of common stock, vesting in full on November 4, 2026.

Concentra Group Holdings Parent, Inc. director Brigid A. Bonner received a grant of 15,496 shares of restricted common stock.

Robert Ortenzio reports a transaction involving the transfer and acquisition of Concentra Group Holdings Parent, Inc. common stock through various trusts.

Douglas R. McAndrew, an executive at Concentra Group Holdings, was granted 60,000 shares of restricted stock that will vest over four years.

Michael A. Kosuth, an executive at Concentra Group Holdings, was granted 60,000 shares of restricted stock that will vest over four years.

Michael D. Rhine, an executive at Concentra Group Holdings, was granted 40,000 shares of restricted stock on November 26, 2024.

Concentra Group Holdings CEO, William Keith Newton, acquired 225,000 shares of restricted stock on November 26, 2024.

Cheryl Pegus, a director at Concentra Group Holdings, received two grants of restricted stock on November 26, 2024, totaling 12,992 shares.

Timothy F. Ryan, Executive Vice President and Chief Legal Counsel of Concentra Group Holdings Parent Inc., received a grant of 60,000 restricted stock units.

Director Marc R. Watkins of Concentra Group Holdings Parent, Inc. received two grants of restricted stock on November 26, 2024, as disclosed in a Form 4 filing.

Danielle Kendall, a Senior Vice President at Concentra Group Holdings, was granted 40,000 shares of restricted stock.

Matthew T. DiCanio, President & Chief Financial Officer of Concentra Group Holdings Parent, Inc., was granted 180,000 shares of restricted stock on November 26, 2024.

Gregory M. Gilbert, an executive at Concentra Group Holdings, was granted 60,000 shares of restricted stock that will vest over four years.

Robert A. Ortenzio, a director at Concentra Group Holdings, acquired 12,992 shares of common stock through restricted stock grants.

Thomas A. Devasia, an executive at Concentra Group Holdings, was granted 60,000 shares of restricted stock that will vest over four years.

John A. deLorimier, an executive at Concentra Group Holdings, was granted 60,000 shares of restricted stock.

Jonathan P. Conser, an executive at Concentra Group Holdings, was granted 60,000 shares of restricted stock that will vest over four years.

Director Daniel Thomas acquired 12,992 shares of restricted stock in Concentra Group Holdings Parent, Inc.

John Robert Anderson Jr., an executive at Concentra Group Holdings, received a grant of 60,000 shares of restricted stock.

Su Zan Nelson, an Executive Vice President at Concentra Group Holdings, was granted 60,000 shares of restricted stock.

Giovanni Gallara, an Executive Vice President at Concentra Group Holdings, was granted 60,000 shares of restricted stock.

Director Daniel Thomas reports acquiring 53,260 shares of Concentra Group Holdings Parent, Inc. common stock as a result of the company's spin-off from Select Medical Holdings Corporation.

Michael D. Rhine, an officer of Concentra Group Holdings Parent, Inc., reported the acquisition of 98 shares of common stock following the company's distribution from Select Medical Holdings Corporation.